Clinical and immunological effects of recombinant interleukin 2 given by repetitive weekly cycles to patients with cancer.

Sondel PM, Kohler PC, Hank JA, Moore KH, Rosenthal NS, Sosman JA, Bechhofer R, Storer B
Cancer Res. 1988 48 (9): 2561-7

PMID: 3258545

MeSH Terms (11)

Cytotoxicity, Immunologic Female Humans Interleukin-2 Leukocyte Count Lymphocytes Male Middle Aged Neoplasms Phenotype Recombinant Proteins

Connections (1)

This publication is referenced by other Labnodes entities:

Links